Whole disease modeling to inform resource allocation decisions in cancer: A methodological framework

Value in Health

Volumn 15, Issue 8, 2012, Pages 1127-1136

  Tappenden, Paul ^a   Chilcott, Jim ^a   Brennan, Alan ^a   Squires, Hazel ^a   Stevenson, Matthew ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

cancer; decision models; economic analysis; methodology; microsimulation

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SCREENING; COLORECTAL CANCER; FAMILY HISTORY; FOLLOW UP; HEALTH ECONOMICS; HEALTH SERVICE; HUMAN; MEDICAL DECISION MAKING; NEOPLASM; PRIORITY JOURNAL; STATISTICS; TERMINAL CARE;

ANTINEOPLASTIC AGENTS; DECISION SUPPORT TECHNIQUES; HEALTH CARE RATIONING; HUMANS; MODELS, ECONOMIC; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME;

EID: 84871255439     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2012.07.008     Document Type: Article

References (41)

1. A.A. Stinnett, and A.D. Paltiel Mathematical programming for the efficient allocation of healthcare resources J Health Econ 15 1996 641 653 (Pubitemid 26423356)
2. J. Raftery Review of NICE's recommendations, 1999-2005 BMJ 332 2006 1266 1268 (Pubitemid 44365421)
3. B. George, A. Harris, and A. Mitchell Cost-effectiveness analysis and the consistency of decision-making-evidence from pharmaceutical reimbursement in Australia (1991 to 1996) Pharmacoeconomics 19 2001 1103 1109 (Pubitemid 33135698)
4. D.M. Clement, A. Harris, and J.J. Li Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia and Canada JAM 302 2009 1437 1443
5. J. Lord, G. Laking, and A. Fischer Health care resource allocation: is the threshold rule good enough? J Health Serv Res Policy 9 2004 237 245 (Pubitemid 39424765)
6. S. Birch, and A. Gafni Cost-effectiveness/cost-utility analyses: do current decision rules lead us where we want to be? J Health Econ 11 1992 279 296
7. C. Mitton, and C. Donaldson Priority-Setting Toolkit: A Guide to the Use of Economics in Healthcare Decision-Making 1st ed. 2009 BMJ Publishing Group London
8. S. Birch, and A. Gafni The biggest bang for the buck or bigger bucks for the bang J Health Serv Res Policy 11 2006 46 51
9. C. Donaldson, G. Currie, and C. Mitton Cost effectiveness analysis in health care: contraindications BMJ 325 2002 891 894 (Pubitemid 35215266)
10. P. Sendi, J.A. Maiwenn, and A. Gafni Optimizing a portfolio of health care programs in the presence of uncertainty and constrained resources Soc Sci Med 57 2003 2207 2215 (Pubitemid 37153160)
11. D. Ruta, C. Mitton, and A. Bate Programme budgeting and marginal analysis: bridging the divide between doctors and managers BMJ 330 2005 1501 1503 (Pubitemid 40897262)
12. Z. Philips, L. Bojke, and M. Sculpher Good practice guidelines for decision-analytic modelling in health technology assessment Pharmacoeconomics 24 2006 355 371
13. M.C. Weinstein, B. O'Brien, and J. Hornberger Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on good research practices-modeling studies Value Health 6 2003 9 17 (Pubitemid 36228345)
14. National Institute for Health and Clinical Excellence Guide to the Methods of Technology Appraisal 2008 National Institute for Health and Clinical Excellence London 1-76
15. M. Gold Cost-effectiveness in Health and Medicine 1st ed. 1996 Oxford University Press New York
16. Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. General methods for the assessment of the relation of benefits to costs. Cologne: IQWiG, 2009, i-55. Available from: https://www.iqwig.de/. [Acessed July 9, 2012].
17. Kaltenthaler E., Tappenden P.,Paisley S., et al. Identifying and reviewing evidence to inform the conceptualisation and population of cost-effectiveness models. National Institute for Health and Clinical Excellence Technical Support Document 13. Sheffield, UK: University of Sheffield, 2011, 1-72. Available from: http://www.dsunice.org.uk. [Accessed July 9, 2012].
18. J.B. Chilcott, P. Tappenden, and A. Rawdin Avoiding and identifying errors in health technology assessment models Health Technol Assess 14 2010 i-135
19. P. Tappenden, J.B. Chilcott, and A. Brennan Systematic review of economic evidence for the detection, diagnosis, treatment and follow-up of colorectal cancer in the United Kingdom Int J Technol Assess Health Care 25 2009 470 478
20. D.M. Eddy, and L. Schlessinger Archimedes: a trial validation model of diabetes Diabetes Care 26 2003 3093 3101 (Pubitemid 37339504)
21. D.M. Eddy Bringing health economic modelling to the 21st century Value Health 9 2006 168 178
22. M.C. Weinstein, P.G. Coxson, and L.W. Williams Forecasting coronary heart disease incidence, mortality and cost: the coronary heart disease policy model Am J Public Health 77 1987 1417 1426 (Pubitemid 18011588)
23. H. Pilgrim, P. Tappenden, and J.B. Chilcott The costs and benefits of bowel cancer service developments using discrete event simulation J Oper Res Soc 60 2008 1305 1314
24. Tappenden P. A methodological framework for developing Whole Disease Models: an application in colorectal cancer. PhD thesis. Sheffield, UK: University of Sheffield, 2011.
25. M. Pidd Tools for Thinking: Modelling in Management Science 2nd ed. 2005 Wiley Chichester, UK
26. S. Robinson Conceptual modelling for simulation, Part II: a framework for conceptual modelling J Oper Res Soc 59 2008 291 304 (Pubitemid 351334692)
27. A. Briggs, K. Claxton, and M. Sculpher Decision Modelling for Health Economic Evaluation 2006 Oxford University Press New York
28. M. Pignone, S. Saha, and T. Hoerger Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force Ann Intern Med 137 2002 96 104 (Pubitemid 34779153)
29. J. Rosenhead, and J. Mingers Rational Analysis for a Problematic World Revisited: Problem Structuring Methods for Complexity, Uncertainty and Conflict 2nd ed. 2004 Wiley King's Lynn, UK
30. Tappenden P. Conceptual modelling to inform health economic model development. Health Economics and Decision Science Discussion Paper. Sheffield, UK: University of Sheffield, 2011.
31. M. Goodland, and C. Slater Structured Systems Analysis and Design Method: A Practical Approach 1995 McGraw-Hill Maidenhead, UK
32. A. Brennan, S.E. Chick, and R. Davies A taxonomy of model structures for economic evaluation of health technologies Health Econ 15 2006 1295 1310 (Pubitemid 44941606)
33. P. Barton, S. Bryan, and S. Robinson Modelling in the economic evaluation of health care: selecting the appropriate approach J Health Serv Res Pol 9 2004 110 118 (Pubitemid 38568540)
34. M. Pidd Computer Simulation in Management Science 5th ed. 2004 Wiley Chichester, UK
35. Taylor D. Methods of model calibration: a comparative approach. Twelfth Annual Meeting of the International Society for Pharmacoeconomics Research. May 19-23, 2007, Virginia, USA.
36. S. Chib, and E. Greenberg Understanding the Metropolis-Hastings algorithm Am Stat 49 1995 327 335 (Pubitemid 126008969)
37. S. Whyte, C. Walsh, and J. Chilcott Bayesian calibration of a natural history model with application to a population model for colorectal cancer Med Decis Making 31 2011 625 641
38. T. Vanni, J. Karnon, and J. Madan Calibrating models in economic evaluation: a seven step approach Pharmacoeconomics 29 2011 35 49
39. A. Briggs, and M. Sculpher An introduction to Markov modelling for economic evaluation Pharmacoeconomics 13 1998 397 409 (Pubitemid 28140699)
40. M. Johannesson, and M.C. Weinstein On the decision rules of cost-effectiveness analysis J Health Econ 12 1993 459 467 (Pubitemid 24037070)
41. P. Tappenden, A. Brennan, and J. Chilcott Using Whole Disease Modelling to inform economic recommendations for the detection, diagnosis, treatment and follow-up of colorectal cancer Value Health 14 2011 A469 A470